Press Releases

News Brief

Samsung Biologics recognized for contribution to sustainability management with Korean Presidential Award

Samsung Biologics recognized for contribution to sustainability management with Korean Presidential Award
 

Samsung Biologics today received the highest Presidential Award for its contribution to sustainability management and industry competitiveness.

 

Hosted by Korea’s Ministry of Trade, Industry, and Energy (MOTIE) and the Ministry of SMEs and Startups, the award is given to companies that have delivered societal value through sustainable management based on their environmental, social, and governance (ESG) performance. Samsung Biologics was recognized for its achievements in responding to climate change, bolstering workplace health and safety, and establishing a system for ESG and risk management.

 

“Samsung Biologics will continue implementing ESG strategies to support the greater industry as we address the largest public health crisis of our time,” said John Rim, CEO and President of Samsung Biologics. “We are committed to strengthening climate-resilient practices to help shape policy across the health sector.”

 

Learn more about our global sustainability initiatives and how we’re advancing decarbonization in our business operations.

Samsung Biologics recognized for contribution to sustainability management with Korean Presidential Award
 

Samsung Biologics today received the highest Presidential Award for its contribution to sustainability management and industry competitiveness.

 

Hosted by Korea’s Ministry of Trade, Industry, and Energy (MOTIE) and the Ministry of SMEs and Startups, the award is given to companies that have delivered societal value through sustainable management based on their environmental, social, and governance (ESG) performance. Samsung Biologics was recognized for its achievements in responding to climate change, bolstering workplace health and safety, and establishing a system for ESG and risk management.

 

“Samsung Biologics will continue implementing ESG strategies to support the greater industry as we address the largest public health crisis of our time,” said John Rim, CEO and President of Samsung Biologics. “We are committed to strengthening climate-resilient practices to help shape policy across the health sector.”

 

Learn more  about our global sustainability initiatives and how we’re advancing decarbonization in our business operations.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION